Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Arthro Kinetics' Asian expansion gathers pace

This article was originally published in Clinica

Executive Summary

Arthro Kinetics (Esslingen, Germany) has made further progress in the Asian orthopaedics market by signing what the company has said to be the first major deals to commercialise its CaReS biologic cartilage regeneration products in the region. The orthopaedic regeneration product company this week inked an agreement with its joint venture partner, Arthro Anda Tianjin Biologic Technology to sell the product line in China, Taiwan and Hong Kong. The joint venture, of which Arthro Kinetics owns around 15%, was established in September 2006 for the production of CaReS using Arthro Kinetics' proprietary 3D collagen matrix for the surgical treatment of large area damage to the knee joint. The manufacturing facility, based in Tianjin, China, is scheduled to open at the end of 2008.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048825

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel